// App-Quantinova.ai

P2-15-09 : Systemic corticosteroid use in patients with metastatic triple-negative breast cancer treated with first-line therapy in the United States

Researchers

Presenter

  • MK Downer

Principal Investigators

  • Patricia Luhn

  • David Miles

  • Matthew Kent

  • Kenneth Russell

  • Joyce OShaughnessy

Medical Centers

  • Genentech, Inc., South San Francisico, CA

  • Mount Vernon Cancer Centre, Northwood, United Kingdom

  • F. Hoffmann-La Roche Ltd., Basel, Switzerland

  • Baylor University Medical Center, Texas Oncology, Dallas, TX

Locations

  • United States

  • United Kingdom

  • Switzerland

Companies

  • Genentech, Inc.

  • F. Hoffmann-La Roche

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Triple-negative breast cancer

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved